During the past decade, Hospital Virgen de la Concha conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Virgen de la Concha" #1 sponsor was "PETHEMA Foundation" with 8 trials, followed by "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 3 trials sponsored, "Dr. Negrin University Hospital" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Virgen de la Concha" #1 collaborator was "Asociación Científica Pulmón y Ventilación Mecánica" with 2 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Consorcio Centro de Investigación Biomédica en Red (CIBER)" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Hospital Arnau de Vilanova" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Virgen de la Concha" are "Multiple Myeloma" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Allergic Rhinoconjunctivitis" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Hospital Virgen de la Concha" in a lesser frequency.

Most popular intervention types in "Hospital Virgen de la Concha" are "Drug" (16 trials), "Device" (3 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARA-C" (2 trials), "AVP-786" (2 trials), "Dexamethasone" (2 trials), "Mitoxantrone" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Virgen de la Concha" are 26 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Virgen de la Concha". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Hospital Virgen de la Concha, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Virgen de la Concha, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".